Maydistacins A-G, Terpestacin-type Sesterterpenoids with Anti-inflammatory Activity from the Phytopathogenic Fungus Bipolaris maydis

J Nat Prod. 2024 Jan 26;87(1):68-76. doi: 10.1021/acs.jnatprod.3c00786. Epub 2023 Dec 20.

Abstract

Seven undescribed terpestacin-type sesterterpenoids, maydistacins A-G (1-7), along with two known congeners (8 and 9), were isolated from the phytopathogenic fungus Bipolaris maydis collected from the leaves of Hypericum longistylum. The structures of 1-7 were elucidated based on extensive spectroscopic analysis, chemical methods, NMR calculations with DP4+ probability analysis, and comparison of experimental and calculated electronic circular dichroism (ECD) calculations. In vitro anti-inflammatory effects of these compounds were tested in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. Compound 1 exhibited inhibition of the production of nitric oxide in LPS-induced macrophages, with an IC50 value of 19 ± 2 μM. A dexamethasone control displayed an IC50 value of 6.7 ± 0.6 μM. Compound 1 is the first terpestacin-type sesterterpenoid reported to display anti-inflammatory activity and may provide a novel chemical scaffold for the discovery of new anti-inflammatory drugs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents* / chemistry
  • Bipolaris*
  • Bridged Bicyclo Compounds
  • Fungi
  • Lipopolysaccharides* / pharmacology
  • Mice
  • Molecular Structure
  • Nitric Oxide
  • RAW 264.7 Cells

Substances

  • Lipopolysaccharides
  • terpestacin
  • Anti-Inflammatory Agents
  • Nitric Oxide
  • Bridged Bicyclo Compounds

Supplementary concepts

  • Bipolaris maydis